Skip to main content
Clinical Trials/CTRI/2022/07/043892
CTRI/2022/07/043892
Not yet recruiting
未知

Etomidate versus propofol as sedative for ERCP - A prospective randomized controlled trial

itin mantri0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhereHealth Condition 2: O- Medical and Surgical
Sponsor
itin mantri
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
itin mantri

Eligibility Criteria

Inclusion Criteria

  • ASA grade I \-II undergoing ERCP in Institute of Liver and Biliary Sciences New Delhi

Exclusion Criteria

  • 1\.Patient refusal
  • 2\.Chronic sedative or opioid analgesic use
  • 3\.Known allergy to the study drugs
  • 4\.Uncontrolled Hypertension
  • 5\.Uncontrolled Diabetes
  • 6\.Presence of Cirrhosis (on imaging \+/\- histology)
  • 7\.Post liver transplant recipients
  • 8\.Heart failure (ejection fraction \<40%,NYHA IV)
  • 9\.Severe respiratory disease (FEV1 \<50%,FVC \<50%)
  • 10\.Porphyria

Outcomes

Primary Outcomes

Not specified

Similar Trials